Announcements
JCCC MINI SYMPOSIUM:
High-throughput Screens in Signal Transduction and Translational Medicine
Monday, June 13th, 2011
ROUNDTABLE MEETINGS
CREB and Pancreatic Cancer
September 13,2010
Cancer Stem Cells
October 26, 2010
PROGRESS REPORT SUBMITTED
The Progress Report for our program area was submitted on August. Scientific progress and achievements were outlined in areas including Signal transduction and tumor analysis and Clinical Translational Studies. The role of the Cancer Center and Future Plans were described. The Progress Report for our program area was submitted in August. Scientific progress and achievements were outlined in areas including Signal transduction and tumor analysis and Clinical Translational Studies. The role of the Cancer Center and Future Plans were described. Please see the highlights below and click here for the full report in pdf CCSG Progress Report 2010
Signaling Pathways: The mTOR signaling pathway the Pten/Akt Signaling CREB metformin GLP-1 metabolic changes in cancer cells small molecule inhibitors of pyruvate kinase M2
Global Analysis, Genomics,Proteomics: Large scale co-expression analysis of disease characterization, phosphoproteome analysis of aortic endothelial cells, salivary biomarkers, salivary miRNA for oral cancer detection
Inhibitors, Nanodelivery, therapy: small molecule inhibitor ABT-869, targeting liposomes, delivery of siRNA using mesoporous silica nanoparticles, significance of cancer stem cells for cancer therapy
Clinical Translational StudiesErbB, PTEN/MTOR, IGF-1R, Hsp90